SYRS Oct 2024 12.500 call
OPR - OPR Delayed Price. Currency in USD
Add to watchlist
As of 01:49PM EDT. Market open.
| Previous Close | 0.5000 |
| Open | 0.5000 |
| Bid | 0.0500 |
| Ask | 0.8500 |
| Strike | 12.50 |
| Expire Date | 2024-10-18 |
| Day's Range | 0.5000 - 0.5000 |
| Contract Range | N/A |
| Volume | |
| Open Interest | 50 |
- GuruFocus.com
Syros Pharmaceuticals Inc (SYRS) (Q1 2024) Earnings Call Transcript Highlights: Strategic ...
Explore key updates on clinical trials, financial shifts, and strategic insights from Syros Pharmaceuticals' Q1 2024 earnings call.
- Thomson Reuters StreetEvents
Q1 2024 Syros Pharmaceuticals Inc Earnings Call
Q1 2024 Syros Pharmaceuticals Inc Earnings Call
Business WireSyros Reports First Quarter 2024 Financial Results and Provides a Corporate Update
CAMBRIDGE, Mass., May 14, 2024--Syros Pharmaceuticals (NASDAQ: SYRS), a biopharmaceutical company committed to advancing new standards of care for the frontline treatment of hematologic malignancies, today reported financial results for the quarter ended March 31, 2024 and provided a corporate update.
© 2024 Yahoo. All rights reserved.